Two recent studies and FDA approval of the first “artificial pancreas” highlight new technological advances in type 1 diabetes care.
Treatment of type 2 diabetes with bariatric surgery was discussed by several recent publications, including updated guidelines from a group of medical specialty organizations.
New data on who to screen for diabetes and how to screen them were offered by a few studies published in the past month.
Three recent studies reanalyzed past data about the effects of intensive glycemic control and published new findings about how and which patients may benefit.
Two recent studies highlighted some differences among ethnic groups in risk and incidence of diabetes.
One study found that personalized text messaging improved patients' self-management while another looked at the potential value of providing social comparisons to other patients' diabetes control.
Several recent analyses of national health care data assessed the prevalence of diabetes and its complications in the U.S.
Renal side effects of diabetes drugs were in the news in the past month, with one industry-funded study finding an association between empagliflozin and slower progression of kidney disease and the FDA strengthening an existing warning on risk of
Intensive blood pressure control may increase diabetic patients' risk of stroke or coronary heart disease, a group of researchers recently concluded in two separate publications.
Knowledge among U.S. patients and clinicians about recommended care for diabetes is good but could still use improvement, one can conclude from studies published this month.